FRUSCIO ROBERT

Katona, B., Lubinski, J., Pal, T., Huzarski, T., Foulkes, W., Moller, P., et al. (2025). The incidence of pancreatic cancer in women with a BRCA1 or BRCA2 mutation. CANCER, 131(1 (1 January 2025)) [10.1002/cncr.35666]. Dettaglio

Cioffi, R., Fruscio, R., Sabetta, G., Bergamini, A., Dell'Oro, C., Scarfone, G., et al. (2025). Consolidation courses in low-risk gestational trophoblastic neoplasia and relapse rate: A MITO-9 retrospective study. GYNECOLOGIC ONCOLOGY, 196(May 2025), 54-58 [10.1016/j.ygyno.2025.03.033]. Dettaglio

Marchetti, C., Fagotti, A., Fruscio, R., Cassani, C., Incorvaia, L., Perri, M., et al. (2025). Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study. ESMO OPEN, 10(4 (April 2025)) [10.1016/j.esmoop.2025.104533]. Dettaglio

Boria, F., Chacón, E., Iyer, R., Fanfani, F., Falcone, F., Bretová, P., et al. (2025). Sentinel SENECA risk factors for unsuccessful bi-lateral sentinel lymph node mapping in endometrial cancer. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 35(5 (May 2025)) [10.1016/j.ijgc.2025.101771]. Dettaglio

Marino, G., Negri, S., Testa, F., Giuliani, D., De Ponti, E., Bombelli, M., et al. (2025). Oncologic and fertility outcome in patients with advanced stage ovarian immature teratomas. GYNECOLOGIC ONCOLOGY REPORT, 58(April 2025) [10.1016/j.gore.2025.101715]. Dettaglio